Article ; Online: Effect of a combination of gliptin and metformin on serum vitamin B12, folic acid, and ferritin levels.
Revista da Associacao Medica Brasileira (1992)
2023 Volume 69, Issue 11, Page(s) e20230641
Abstract: Objective: The primary objective of this study was to explore the impact of metformin and metformin/gliptin combination therapy on the serum concentrations of vitamin B12, ferritin, and folic acid in individuals diagnosed with type 2 diabetes.: ... ...
Abstract | Objective: The primary objective of this study was to explore the impact of metformin and metformin/gliptin combination therapy on the serum concentrations of vitamin B12, ferritin, and folic acid in individuals diagnosed with type 2 diabetes. Methods: This study included 118 patients, classified into two groups: 59 patients using only metformin and 59 patients using a combination of metformin/gliptin. Among the latter group, 35 patients used vildagliptin/metformin, and 24 used sitagliptin/metformin. The study recorded the demographic data such as the age and gender of the patients, as well as their initial and 1-year follow-up blood parameters. Results: Folic acid decreased significantly in the metformin group but not in the metformin/gliptin group. Vitamin B12 and ferritin decreased significantly in both groups. The decrease in vitamin B12 and ferritin was not significantly different between the two groups. The decrease in fasting plasma glucose was more significant in the metformin/gliptin group than in the metformin group. Conclusion: After 1 year, both groups taking metformin and metformin/gliptin showed low serum ferritin and vitamin B12 levels. Therefore, vitamin B12 levels in patients using these drugs should be closely monitored. Ferritin levels can be used to indicate whether glycemic control has been achieved. |
---|---|
MeSH term(s) | Humans ; Metformin/therapeutic use ; Folic Acid/therapeutic use ; Diabetes Mellitus, Type 2/drug therapy ; Hypoglycemic Agents/therapeutic use ; Dipeptidyl-Peptidase IV Inhibitors/therapeutic use ; Vitamin B 12/therapeutic use ; Ferritins |
Chemical Substances | Metformin (9100L32L2N) ; Folic Acid (935E97BOY8) ; Hypoglycemic Agents ; Dipeptidyl-Peptidase IV Inhibitors ; Vitamin B 12 (P6YC3EG204) ; Ferritins (9007-73-2) |
Language | English |
Publishing date | 2023-10-27 |
Publishing country | Brazil |
Document type | Journal Article |
ZDB-ID | 731969-1 |
ISSN | 1806-9282 ; 0104-4230 ; 0004-5241 ; 0102-843X |
ISSN (online) | 1806-9282 |
ISSN | 0104-4230 ; 0004-5241 ; 0102-843X |
DOI | 10.1590/1806-9282.20230641 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.B 654: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.